Project Grant K23AG102190
- Federal Project Grant Award Summary The University of California, San Diego received a $3.14 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 15, 2025, with completion targeted for August 31, 2029. This research initiative will deliver comprehensive scientific analysis of human brain neuropeptidomes and their biosynthetic proteases in normal aging and Alzheimer's disease (AD) conditions. The project will elucidate the...
- Federal Project Grant Summary Sri International received a $1.26 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 15, 2025, with completion targeted for August 31, 2027. The grant supports research on glymphatic magnetic resonance imaging and biomarker discovery in aging populations with human immunodeficiency virus (HIV) infection. The project addresses the elevated risk of cognitive decline and neurological...
- Federal Project Grant Award Summary The University of California, San Diego received a $165,488 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded March 1, 2026, with completion targeted for November 30, 2028. This award supports research to reduce misdiagnosis in Alzheimer's disease through artificial intelligence-driven biomarker identification. The project delivers three primary research products: (1) construction of a...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $422,125 Project Grant to the University of Nebraska Medical Center (UNMC), Board of Regents of the University of Nebraska, effective June 1, 2026, through May 31, 2028, under the Aging Research program (CFDA 93.866). This award funds research investigating the roles of misfolded protein aggregates on latent viral reservoirs in simian immunodeficiency virus (SIV)-infected, antiretroviral therapy (ART)-treated aged rhesus...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $674,455 Project Grant to the University of California, San Diego, effective July 1, 2026, through March 31, 2031, under the Aging Research program (CFDA 93.866). This award supports research investigating the role of vascular sphingolipid metabolism in Alzheimer's disease pathogenesis. The project delivers scientific research services focused on identifying how cerebral blood vessel dysfunction contributes to...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $690,934 Project Grant to the University of California, Davis, effective March 1, 2026, through November 30, 2030, under the Aging Research program (CFDA 93.866). This research initiative investigates subjective cognitive decline (SCD)—self-perceived cognitive decline despite normal cognitive test performance—as an early indicator of Alzheimer's disease and related dementias (AD/ADRD) across diverse racial and...
- Federal Grant Award Summary The University of California, San Diego (UCSD) received a $150,512 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded August 2, 2026, with a completion date of August 1, 2027. This project develops a novel, validated diffusion magnetic resonance imaging (MRI) biomarker to enable early detection of Alzheimer's disease (AD) through identification of microstructural changes in gray matter. The research...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded $439,750 to the University of California, San Diego on May 15, 2026, under the Aging Research program (CFDA 93.866) to support a two-year research project examining changes in hippocampal coding of very large spaces from adulthood to senescence. The research addresses a critical gap in understanding Alzheimer's disease progression by investigating the role of the ventral and dorsal hippocampus in spatial navigation...
- Federal Project Grant Award Summary The University of California, Los Angeles received a $146,750 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded July 1, 2026, with an ultimate completion date of April 30, 2031. This award supports research to identify molecular-neuropathological signatures across Alzheimer's Disease (AD), Frontotemporal Lobar Degeneration (FTLD), and Long COVID through single-cell spatial multi-omics analysis of...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $163,080 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 9, 2025, with completion targeted for July 31, 2030. This K08 Career Development Award supports research to advance plasma biomarkers for Alzheimer's Disease and Related Dementias (AD/ADRDS) toward appropriate clinical and research use in diverse populations, addressing...
The National Institute on Aging (NIA) awarded a Project Grant totaling $163,867 to the University of California, San Diego, effective July 1, 2026, through April 30, 2031, under the Aging Research program (CFDA 93.866). This K23 career development grant supports research aimed at discovering and classifying novel metabolite biomarkers of neurocognitive impairment (NCI) in older people with HIV (PWH) through the application of untargeted metabolomics and machine learning methods. The research leverages existing cohort data from the UC San Diego HIV Neurobehavioral Research Center and the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Study, comprising approximately 403 and 598 PWH participants respectively, to identify candidate biomarkers in fecal, cerebrospinal fluid, and plasma samples and validate findings across multiple biological matrices. The grant funds cross-disciplinary research addressing a critical gap in NeuroHIV science by integrating metabolomics—which quantifies small molecule byproducts of metabolic processes to assess health status—with advanced data-driven analytical approaches. The research responds to recent NIH initiatives promoting the development of biotypes for HIV brain health disorders by providing unprecedented biological insights into the complex heterogeneity of NCI in older PWH, a population experiencing neurocognitive complications despite widespread viral suppression from antiretroviral therapy. This project represents a systematic effort to establish metabolite-based diagnostic and prognostic tools for understanding the synergistic effects of HIV and aging on neurological function.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $163.9k | 6/29/26 |